AIU found Okagbare guilty of use of a prohibited substance following the detection of Human Growth Hormone in a sample collected
The Athletics Integrity Unit (AIU), has banned Nigerian sprinter, Blessing Okagbare for 10 years for doping offence.
AIU said the 33-year-old athlete was banned for five years for the use of multiple prohibited substances and five for not cooperating with the investigation.
Okagbare was suspended during the Tokyo Olympics after failing a drug test.
“The Disciplinary Tribunal has banned Nigerian sprinter Blessing Okagbare for a total of 10 years,” read an AIU statement.
Brett Clothier, head of the AIU, described the 10-year ban as “a strong message” against cheats.
The AIU had in October suspended investigations on Okagbare, following her refusal to provide documents that would assist in the investigation.
“As the process is ongoing the AIU will make no further comment on the matter at this time,” says AIU.
In a press statement obtained by TheNiche, the Athletics Integrity Unit (AIU) further said it issued charges against Nigerian sprinter Blessing Okagbare in relation to three separate disciplinary matters.
“Specifically, it is alleged that the athlete failed to comply with a formal requirement to produce relevant documents, records and electronic storage devices, which was issued to the athlete by the AIU on 15th September.
“The athlete denies all charges and has requested that each of them be submitted to a hearing before the Disciplinary Tribunal.
“The athlete has been charged with the presence and use of a prohibited substance following the detection of Human Growth Hormone in a sample collected out-of-competition on 19th July in Slovakia and reported to the AIU on 30th July.
“This matter was publicly announced on 31st July when Ms Okagbare was provisionally suspended.
“She had been scheduled to participate in the semi-finals of the Tokyo 2020 women’s 100m that day.
“The athlete has also been charged with the presence and use of a prohibited substance following the detection of recombinant erythropoietin (EPO) in a sample collected out-of-competition on 20th June in Nigeria.
“The AIU requested EPO analysis be conducted on the sample on 29th July and the adverse analytical finding was reported to the AIU on 12th August. Ms Okagbare was notified of the adverse analytical finding on 20th August.
“Human Growth Hormone and EPO are non-specified substances on the 2021 World Anti-Doping Agency (WADA) Prohibited List.
“A provisional suspension is mandatory following an adverse analytical finding for such a substance under the World Athletics Anti-Doping Rules and the athlete remains provisionally suspended.
“Finally, the AIU has issued a further charge against Ms Okagbare in accordance with Rule 12 of the World Athletics Anti-Doping Rules following the athlete’s refusal to co-operate with the AIU’s investigation into her case.”
